Valuation: Abbott Laboratories

Market Cap 161B 141B 130B 121B 228B 15,265B 233B 1,561B 605B 7,493B 603B 590B 26,077B P/E 2026 *
22.8x
P/E 2027 * 19.5x
Enterprise Value 172B 151B 139B 130B 245B 16,376B 250B 1,674B 649B 8,038B 647B 633B 27,976B EV / Sales 2026 *
3.43x
EV / Sales 2027 * 3.09x
Free-Float
86.73%
Yield 2026 *
2.76%
Yield 2027 * 2.95%
1 day+1.59%
1 week+1.87%
Current month+1.59%
1 month+5.01%
3 months-9.96%
6 months-26.43%
Current year-26.43%
1 week 90.61
Extreme 90.61
95.21
1 month 86.72
Extreme 86.72
95.21
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
137.49
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Date Insider Type Main position Quantity % Market Cap.
06-26Tax

General Counsel

-560 0.0000%
04-27Other

Head of Human Resources

5,314 0.0003%
04-23Free

Director

2,286 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+1.59%+1.87%-32.35%-15.45% 158B
+1.24%-1.16%-10.76%-10.10% 100B
+1.92%+1.39%-2.34%+49.88% 55.06B
-0.14%-0.96%+56.03%+49.49% 53.4B
+1.04%+3.47%-13.94%-42.09% 41.7B
+5.81%+15.76% - - 33.35B
+2.24%-1.28%-17.61%-46.42% 25.99B
+1.67%+7.22%+64.10%-4.57% 25.36B
+0.82%+2.48%-12.51%-5.64% 20.52B
+3.66%+2.10%-11.08%-2.08% 20.27B
Average +2.00%+2.95%+2.17%-2.99% 53.38B
Weighted average by Cap. +1.70%+1.92%-6.44%-2.59%

Financials

2026 *2027 *
Net sales 50.26B 44.13B 40.62B 37.85B 71.38B 4,778B 72.83B 489B 189B 2,345B 189B 185B 8,162B 54.75B 48.07B 44.25B 41.23B 77.76B 5,205B 79.34B 532B 206B 2,555B 206B 201B 8,892B
Net income 7.02B 6.16B 5.67B 5.29B 9.97B 667B 10.17B 68.22B 26.43B 328B 26.35B 25.78B 1,140B 8.39B 7.37B 6.78B 6.32B 11.91B 798B 12.16B 81.55B 31.6B 392B 31.5B 30.82B 1,363B
Net Debt 11.69B 10.26B 9.45B 8.8B 16.6B 1,111B 16.94B 114B 44.02B 545B 43.89B 42.94B 1,898B 8.86B 7.78B 7.16B 6.67B 12.58B 842B 12.83B 86.09B 33.36B 413B 33.26B 32.54B 1,438B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-07-01 US$92.18 +1.59% 13,935,849
26-06-30 US$90.74 -2.12% 10,021,142
26-06-29 US$92.71 -1.50% 10,314,404
26-06-26 US$94.12 +0.94% 16,465,117
26-06-25 US$93.24 +3.04% 16,708,691
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
92.18USD
Average target price
116.72USD
Spread / Average Target
+26.62%

Quarterly revenue - Rate of surprise